Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
$R25IGTRI Russell 2500 Growth TR Index
QQQ Invesco QQQ Trust
PRDO Perdoceo Education Corp
DITHF DS Smith PLC
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
ASTA WorldFlix Inc
Go


Based in Canada
Company profile

Cybin Inc., formerly Clarmin Explorations Inc., is a Canada-based life sciences company. The Company is focused on developing psychedelic pharmaceutical and non-psychedelic nutraceutical-based products. Its subsidiaries include Natures Journey Inc. and Serenity Life Sciences Inc. Serenity Life Sciences Inc. is focused on research and development of psilocybin-based medications. Natures Journey Inc. operates the Journey brand, which specializes in developing medicinal mushroom products. It has a drug delivery platform developed to administer psychedelic therapies and bypass liver metabolism. The Company also focus is on the development of treatment regimens consisting of psychedelic molecules and related clinical protocols.

Closing Price
$1.97
Day's Change
-0.05 (-2.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.09
Day's Low
1.89
Volume
(Heavy Day)
Volume:
1,528,204

10-day average volume:
795,816
1,528,204
  • Prev Close
    2.02
  • Today's Open
    2.09
  • Day's Range
    1.89-2.09
  • Avg Vol (10-day)
    795.8K
  • Last (time)
    8:00p ET 10/15/21
  • Last (size)
    2
  • 52-Wk Range
    0.4938 - 3.38
    LowHigh
  • (11/20/20 - 08/02/21)
    41.72%
  • 265.6%
  • Market Cap
    331.7M
  • Shares Outstanding
    168.4M
  • -0.33
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 2.57
  • (% of float 09/30/21)
    0.47

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.